1.
Impact of Socioeconomic Status on Cancer Incidence and Stage at Diagnosis: Selected Findings from the Surveillance, Epidemiology, and End Results: National Longitudinal Mortality S...
by Clegg, Limin X
Cancer causes & control, 2009, Vol.20 (4), p.417-435
2.
Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges
by Mondul, Alison M
Epidemiologic reviews, 2017, Vol.39 (1), p.28-48
3.
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
by Maringe, Camille
The lancet oncology, 2020, Vol.21 (8), p.1023-1034
4.
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary p...
by Katsumata, Noriyuki, Prof
The lancet oncology, 2013, Vol.14 (10), p.1020-1026
5.
Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
by Spiliotis, J
Annals of surgical oncology, 2014, Vol.22 (5), p.1570-1575
6.
Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
by Solass, Wiebke
Annals of surgical oncology, 2013, Vol.21 (2), p.553-559
7.
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
by Vergote, Ignace
The lancet oncology, 2018, Vol.19 (12), p.1680-1687
8.
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer reg...
by Coleman, MP, Prof
The Lancet (British edition), 2011, Vol.377 (9760), p.127-138
9.
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gas...
by Doi, Toshihiko
The lancet oncology, 2017, Vol.18 (11), p.1512-1522
10.
Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer
by Chang, Suk-Joon
Annals of surgical oncology, 2012, Vol.19 (13), p.4059-4067
11.
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
by Yuen, Kobe C
Nature medicine, 2020, Vol.26 (5), p.693-698
12.
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
by Cunningham, David, Prof
The lancet oncology, 2013, Vol.14 (11), p.1077-1085
13.
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial
by Fizazi, Karim, Prof
The lancet oncology, 2014, Vol.15 (13), p.1442-1450
14.
Association between Metabolic Syndrome and Cancer
by Uzunlulu, Mehmet
Annals of nutrition and metabolism, 2016, Vol.68 (3), p.173-179
15.
Mortality and cancer incidence in a pooled cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950–2009)
by Daniels, Robert D
Occupational and environmental medicine (London, England), 2014, Vol.71 (6), p.388-397
16.
Abdominal Desmoplastic Small Round Cell Tumor: Multimodal Treatment Combining Chemotherapy, Surgery, and Radiotherapy is the Best Option
by Honoré, Charles
Annals of surgical oncology, 2014, Vol.22 (4), p.1073-1079
17.
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
by van Zandwijk, Nico
The lancet oncology, 2017, Vol.18 (10), p.1386-1396
18.
Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid Cancer
by Shin, Dong Wook
Annals of surgical oncology, 2013, Vol.20 (8), p.2468-2476
19.
Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon
by Streppel, Mirte M., MD
Human pathology, 2012, Vol.43 (10), p.1755-1763
20.
Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Sur...
by Forget, Patrice
Annals of surgical oncology, 2013, Vol.20 (Suppl 3), p.650-660
